HIT
- AI / ML
- Alternative Therapies
- Alzheimer(s) Disease
- Anxiety
- Art in Healthcare
- Autism
- Autoimmune Disorders
- BigData
- Biotech
- BIPOC Founders
- Blockchain
- Breast Cancer
- Cancer Care
- Cardiovascular Disease
- Clinical Interventions
- Coaching
- Community
- Connected Health
- COVID-19
- Dental
- Depression
- Diabetes
- Diagnostics
- Drug Development
- Emergency Medicine
- Equity Raise
- Family Caregivers
- Female Founders
- Fitness or Wellness
- For the Doctors Office
- Genetic Disorders
- Geriatric Medicine
- Hard to Categorize
- Healthy Living
- HIT
- Home-Based Care
- Hospital Solutions
- Infectious Disease
- Informatics
- InsureTech
- Interoperability
- Investment Banking
- LGBTQIA Founders
- Longevity
- Managed Care
- Maternal Health
- Medical Device
- Medical Education
- Men's Health
- Mental Health
- Minority Founders
- Neurology
- New Practice
- Open Data
- Orthopedics
- Other - Disease Related
- Pain Management
- Palliative Care
- Pancreatic Cancer
- Parkinson's disease
- Patient and Provider Tools
- Patient Education
- Patient Power Tools!
- Payer Innovations
- Pediatric care
- Pet Projects
- PharmaTech
- Population Health
- Precision Medicine
- Prevention
- Public Health
- Pulmonary/ Asthma
- Rare Diseases
- Regenerative Medicine
- Rheumatoid Arthritis
- RPM
- Sexual Health
- Substance Abuse
- Wearables
- Women(s) Health
All Categories
All AMIA community companies
PebbleSpot.com
Cedars-Sinai Health System
Academic Innovation Accelerator
ProCARE Portal
Ardha Health
SafeStart Medical, Inc.
Folia Health, Inc.
Intelligent Medical Objects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.